Risk of Malignancy, Major Adverse Cardiovascular Events, and Liver Injury in Patients with Ulcerative Colitis Treated with Mirikizumab versus Other Biologics: A Secondary Database Study in Japan

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000001009
• Study ID:
  1000001009
• Official title and acronym:
  Risk of Malignancy, Major Adverse Cardiovascular Events, and Liver Injury in Patients with Ulcerative Colitis Treated with Mirikizumab versus Other Biologics: A Secondary Database Study in Japan
• DARWIN EU® study:
  No
• Study countries:
  Japan
• Study description:
  No information provided.
• Study status:
  Planned

Study timelines

Date when funding contract was signed

Planned:31/08/2031

Study start date

Planned:31/08/2031

Date of final study report

Planned:31/05/2033

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only